Useful MyOrbitHealth alternatives include TEHR and the seven options below, depending on the operating work your team needs to replace or retain. TEHR publishes this list and places itself first; the order is editorial, not independent testing or a scored ranking.
Why are you considering an alternative to MyOrbitHealth?
A useful search begins with the constraint that triggered it. Perhaps the required onboarding investment is too large, your existing application must remain, or your program needs a particular diagnostic workflow. A team may also be satisfied with the software but need a different support arrangement. These are different buying problems. Record the constraint in a sentence and make each shortlisted vendor demonstrate how it resolves it without creating a larger obligation elsewhere.
MyOrbitHealth describes hosted and embedded options on its platform page. Therefore, an alternative should not be selected on the false premise that it only offers one implementation route. Read the TEHR versus MyOrbitHealth comparison for the direct scope discussion, then use this list to widen the decision. The strongest shortlist contains vendors that fit your nonnegotiable requirements, not simply companies with similar homepage language. Preserve useful existing assets unless replacing them has a measurable operational benefit.
Which buying question should each option answer?
Public claims below were reviewed as of October 22, 2026. These evaluation focuses are editorial guidance, not scores. A missing public answer remains unknown until a vendor confirms it; it is not proof that a feature is absent.
| Option | Evaluation focus | Confirm before selection |
|---|---|---|
| TEHR | Brand operations and existing patients | Scope, economics and cutover responsibilities |
| MyTelemedicine | Clinical access inside an organization | Which business functions remain outside |
| WhiteLabelMD | Outsourced operating services | Deliverables and continuing commercial terms |
| Qualiphy | A consultation within a wider workflow | What surrounds the clinical encounter |
| Karpa Health | Practice or audience-led expansion | The exact operating path and program scope |
| Remedora | Commerce and fulfillment coordination | Total services beyond platform access |
| Bask Health | Configurable DTC workflows | Current plan and integration responsibilities |
| Healthie | Practice and patient-management foundation | Enterprise scope and separately sourced services |
When should TEHR lead your evaluation?
TEHR fits an evaluation centered on owning and operating a branded health business with coordinated technology and administrative infrastructure. Independent licensed clinicians provide care, while the platform supports intake, payments, subscriptions and pharmacy coordination. Its operators ran DudeMeds, Peptiders, TellyMeds and FansMeds and migrated thousands of their own patients. That background should support a detailed operational conversation, not replace product verification.
Ask TEHR to demonstrate the patient journey you actually need through the platform. Its flat subscription plus flat transaction fee and 0% revenue share require a scoped quote. The trade-off to resolve is how much operating work the proposal assigns to your team versus TEHR and its service partners.
When is MyTelemedicine the more relevant alternative?
MyTelemedicine describes configurable virtual-care technology and clinical access on its official platform page. It deserves consideration when an existing organization needs to add care to a product or service rather than replace its entire consumer business infrastructure.
Bring an architecture and responsibility map to the demo. Identify the patient entry point, eligibility logic, record system and follow-up owner. The strength of a broad enterprise proposition is meaningful only when it connects to your specific operating environment. The trade-off is that you must confirm commerce, fulfillment and customer-support duties explicitly; a clinical-access proposal should not be assumed to contain every function a new DTC brand needs.
When does a managed WhiteLabelMD proposal make sense?
WhiteLabelMD’s launch page describes full-service and hybrid support arrangements. Consider it when the reason for leaving a platform is not a missing feature but a shortage of staff and operational capacity.
Ask for recurring deliverables, service levels and account ownership rather than accepting “done for you” as a complete scope. A managed arrangement may remove work your company would otherwise hire for, but it also creates dependencies you should understand at renewal or exit. Request the exact commercial model and compare it over a realistic customer lifetime. The decision is whether the outsourced responsibilities justify their continuing cost, not whether a managed service is inherently better or worse than software.
When can Qualiphy solve a narrower problem?
Qualiphy’s pricing page offers consultations without a monthly subscription. That model is relevant when you already have a functional brand, customer service and payment infrastructure and mainly need a clinical encounter capability.
Define what happens before the encounter and after the provider’s decision. If your current application handles those stages well, replacing it could be unnecessary. If those stages are the source of your operational problems, an encounter service alone may leave the work unresolved. Check state and program eligibility, follow-up requirements and the destination of clinical information. The trade-off is the amount of coordination your own systems and staff must continue to perform around each consultation.
When should an established practice consider Karpa?
Karpa’s functional-medicine page explicitly describes support for importing existing patient records and active workflow information. It is a relevant alternative when you have a current patient panel and want to evaluate how a new cash-pay operating layer would fit the practice.
Ask for a representative import and examine the resulting state of a patient approaching a refill. Verify what remains in the existing EHR and what becomes operationally authoritative in the new platform. The strength is a stated practice-oriented use case; the trade-off is that the actual migration still depends on your records and responsibilities. Do not assume that a public migration statement includes every source system, payment token or historical document.
When should Remedora enter the shortlist?
Remedora presents commerce and clinical coordination together on its platform page. Consider it if the constraint is operational visibility across the consumer funnel, orders and fulfillment rather than a specific need to preserve an embedded application.
Use a failed or delayed order as the demonstration scenario. Ask how an operator knows what has happened, who acts next and what the patient sees. A connected console can be valuable if it reduces reconciliation work, but it should not obscure the separate responsibilities of licensed clinicians and pharmacies. Model the total service costs and confirm data portability. The trade-off is whether adopting its operating environment fits the assets and workflows your team intends to keep.
When does Bask Health fit a builder-led approach?
Bask’s plans page describes a DTC builder with clinical and pharmacy workflows, not merely a decorative storefront. It belongs on the shortlist when the brand wants to configure the patient experience and manage its own commercial execution.
Have the people who will operate the system perform a realistic change during the demo: update an offer, inspect an intake exception and trace an order through its clinical and fulfillment stages. The trade-off is configuration responsibility. A flexible builder may still require your team to own content, integration decisions and quality checks. Confirm the current plan and services directly rather than combining statements from different dated pricing pages into a package the vendor has not quoted.
When is Healthie a better foundation to preserve?
Healthie’s white-label catalog offers an Enterprise branding option. Consider it when the core requirement is practice and patient-management software around an existing care organization, rather than outsourcing the entire brand operation.
Separate the software decision from staffing and fulfillment. If your clinical team and service relationships already work, a strong practice foundation may be more useful than a turnkey replacement. If those relationships are missing, the proposal must identify how they will be supplied. The trade-off is assembly and coordination. Enterprise white-label scope should be priced separately; an entry-level software subscription is not a fair proxy for a staffed nationwide consumer health business.
How should you compare an embedded build with a hosted replacement?
List the components you intend to retain: domain, application, identity system, payment processor, analytics, CRM and clinical record environment. Then define the events that must cross system boundaries. The vendor should demonstrate supported interfaces for those events, not only promise API availability. Identify authentication, error handling, reconciliation and responsibilities when one system is unavailable.
For a hosted replacement, inspect the degree of configuration your staff can control and the process for changes they cannot make themselves. For an embedded route, estimate implementation and maintenance effort as well as platform fees. Read what white-label infrastructure includes and ensure the team is comparing equivalent service models. A cheaper monthly subscription can become expensive if your staff must build and maintain the missing operating connections.
What should the final decision packet include?
Prepare the scoped commercial quote, program coverage, service responsibilities, acceptance tests and migration plan before selecting a vendor. Run the same assumptions through each financial model, including support demand and clinical follow-up. TEHR’s pricing page explains its commercial structure, while exact amounts belong in a proposal.
Use the patient migration checklist to separate records, active clinical states, subscriptions and payment portability. Include a small pilot, reconciliation reports and a rollback decision. Keep future features separate from available services; selected TEHR peptide programs remain pending and are not open for prescribing or fulfillment. The resources hub can support the planning work, but the choice should be settled by demonstrated workflows and accountable contract terms.
What else should you know?
What is the best MyOrbitHealth alternative?
There is no universal answer. TEHR is worth evaluating for branded operating infrastructure; other options may fit an embedded product, an existing practice or a focused consultation requirement. Start with the specific constraint you need to solve and compare equivalent scopes.
Should I switch just to lower a monthly fee?
Only after calculating the full effect. Include implementation, clinical services, pharmacy and lab costs, staff work and transition disruption. A lower subscription can still leave the business with more manual coordination or a larger migration project.
Can I retain my own storefront?
Ask each vendor to demonstrate the intended integration rather than relying on a broad API claim. Identify ownership of checkout, identity, intake, clinical status and patient messages. Retaining a storefront is useful only if those responsibilities remain coherent.
How do I compare lab support?
Specify panels, collection geography, ordering clinicians, result review and specimen exceptions. A lab logo does not describe the complete service. Confirm charges and current availability, especially when a proposed TEHR workflow is not yet represented as a standalone lab product.
Which sources support this guide?
Public sources reviewed as of 2026-10-22. Vendor statements describe the vendor’s published offering; your contract determines actual scope.
Build around your operation.
Discuss your categories, patient experience and costs with TEHR.